This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Medicine purchases: ATC
A10BA
1 out of 7 registries used, show all original rules.
59445
Check minimum number of events
Min. number of events
3
59445
Include endpoints None
59445
Remove individuals based on genotype QC
57257
BIGUANIDES
Control definitions
Control exclude
DIAB_MED_OTHER
Extra metadata
First used in FinnGen datafreeze
DF2
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to
Biguanides
based on the number of shared cases.
Broader endpoints:
- Other (not insulin) diabetes medications
- Diabetes medication
- Type 2 diabetes
- Diabetes mellitus
- Endocrine, nutritional and metabolic diseases
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 57257 | 25635 | 31622 |
| Unadjusted prevalence (%) | 13.90 | 11.13 | 17.40 |
| Mean age at first event (years) | 59.25 | 57.83 | 60.40 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: BIGUANIDES – Biguanides
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Biguanides
↥Endpoint not on priority list, no data to show.